Bicycle Therapeutics Is A Clinical Stage Biopharmaceutical Company Founded In 2009Based In Cambridgeukwith Significant Operations In Cambridgemathe Company Specializes In Developing Precision Guided Therapeutics Using Its Proprietary Bicycleatechnology Platformfocusing On Unmet Medical Needs In Oncology And Other Therapeutic Areas Bicycle Therapeutics Aims To Lead In Solid Tumor Therapeutics By Creating Syntheticconstrained Peptides Known As Bicyclesthese Fully Synthetic Short Peptides Are Designed To Effectively Penetrate Tissues And Target Difficult Cancer Pathwaysthe Company S Clinical Pipeline Includes Several Candidatessuch As Bt5528Bt8009Bt7480And Bt1718Which Target Various Tumor Antigens And Are In Different Stages Of Clinical Trialsadditionallybicycle Is Developing Bicycle Radio Conjugatesbrca Cfor Radiopharmaceutical Applications The Company Collaborates With Pharmaceutical Companies And Academic Institutions To Expand Its Technology Into Non Oncology Areasincluding Anti Infectivescardiovascular Diseasesand Central Nervous System Disordersbicycle Therapeutics Is Committed To Developing Transformative Medicines For Cancer Patients And Aims To Address Broader Patient Populations In Underserved Therapeutic Areas
